Syncricity
Syncricity
  • Home
  • About Us
  • Contact Us

reimagine living ...

reimagine living ...reimagine living ...reimagine living ...

reimagine living ...

reimagine living ...reimagine living ...reimagine living ...

Delivering real-time controllable relief from spasticity, and returning functional muscle control for people with conditions like cerebral palsy, multiple sclerosis and spinal injuries.

The Idea

Founder/CEO Joe Dusseldorp, leading reconstructive surgeon, aims to help the millions of patients worldwide with spasticity who at present have to make some compromising choices in search of relief from constant muscle over-contraction. “You can either permanently sever the nerve controlling the muscle, or disable the muscle for a period of months through locally injecting Botox or drip feeding Baclofen. The issue with those treatments is you can’t turn them off for a minute to restore some muscle tone to help you put on your clothes or get out of your wheelchair.”

Syncricity is building implants that are orders of magnitude cheaper and smaller than traditional neuromodulation systems. A series of them can be inserted easily alongside targeted peripheral nerves, then powered and controlled from outside the body by a battery powered, body worn controller. The nerve blocking signal does not damage the nerves and has already been proven by multiple scientific teams to be effective in stopping muscle contraction. 

Recent advancements in wireless power transfer technology are enabling this next generation of implants - the size of a grain of rice - to be implanted as deep as 5 cm or more. Patient and customer research shows a strong desire for this solution over incumbents. Health economics show an average lifetime saving over incumbents. Syncricity has gained significant traction in innovation competitions and grants, and has established a credible set of design and advisory partners. 

Progress

Building Better Futures for Health 2024

Syncricity was the major winner of the 2024 BBFH Challenge, a Healthcare Startup Competition offered by IDE Group. Competing with medtech innovators across Australia, the Netherlands and Colombia, we are honoured to receive a prize package valued at up to $40,000 in design, development, and commercialisation services from IDE Group.


National Bionics Innovation Prize 2022

Syncricity was the National Bionics Innovation Prize Winner in the Bionics Challenge 2022 conducted by Bionics Queensland. You can watch the pitch now in the video to the left.


Read more about how the team aims to accomplish their mission in this article in Hospital and Healthcare Magazine. 

Contact Us

Read more

Download PDF

Copyright © 2024 Syncricity - All Rights Reserved.


Powered by GoDaddy

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept